Financial Performance Highlights (Standalone Basis)

Revenue Performance:

  • Total Revenue from Operations: ₹7,166 lakh for FY26
  • Year-over-Year Growth: +13.6%
  • H2 FY26 Revenue from Operations: ₹3,727.85 lakh
  • H1 FY26 Revenue from Operations: ₹3,438.57 lakh
  • H2 YoY Growth: +11.38% compared to H2 FY25 (₹3,346.87 lakh)

Profitability Metrics:

  • Profit After Tax (PAT): ₹2,142 lakh for FY26
  • PAT Growth: +17.6% Year-over-Year
  • H2 FY26 PAT: ₹1,121.44 lakh
  • H1 FY26 PAT: ₹1,020.38 lakh
  • H2 YoY PAT Growth: +15.48% compared to H2 FY25 (₹971.14 lakh)

Margin Performance:

  • EBITDA Margin: 39.8% for FY26 (80 bps improvement)
  • H2 FY26 EBITDA Margin: 39.92%
  • H1 FY26 EBITDA Margin: 39.73%
  • PBT Margin: Improved by 110 bps
  • PAT Margin: Improved by 80 bps

Quarterly Performance (Q4 FY26):

  • Sequential Q4 EBITDA growth: 15.9% over Q3 FY26
  • QoQ PBT Growth: 21.2%
  • QoQ PAT Uplift: 23.3%

Consolidated Financial Performance

Full Year FY26 Consolidated:

  • Revenue from Operations: ₹7,180.85 lakh (+13.9% YoY)
  • EBITDA: ₹2,962.11 lakh (+13.3% YoY)
  • Profit Before Tax (PBT): ₹2,761.23 lakh (+13.9% YoY)
  • Profit After Tax (PAT): ₹2,049.05 lakh (+12.9% YoY)

Half-Yearly Consolidated Performance:

  • H2 FY26 Revenue: ₹3,740.01 lakh
  • H2 FY26 EBITDA: ₹1,526.90 lakh (38.21% margin)
  • H2 FY26 PBT: ₹1,425.22 lakh
  • H2 FY26 PAT: ₹1,054.22 lakh

Operational and Business Highlights

Global Presence:

  • Export to over 90 countries worldwide
  • 145+ dealers in India
  • 120+ overseas distributors
  • Product portfolio exceeding 100 products

Manufacturing Capacity:

  • 60,000-square-foot manufacturing facility in Jammu
  • Advanced technology and in-house R&D lab

Strategic Expansion:

  • Established Axiodent Inc. for US market entry
  • Established Prevest Gulf LLC for UAE market presence
  • Capital infusion in Prevest Gulf LLC subsidiary

Quality Accreditations:

  • ISO 13485-2016 certification
  • USFDA approval
  • EC Certificate
  • ISO 22716 certification
  • Saudi FDA (SFDA) compliance
  • MDSAP certification for USA, Canada & Brazil

Strategic Partnerships:

  • MOU with Indian Dental Association for clinical education
  • MOU with IIT Kanpur for development and manufacturing of biomaterials and biomedical devices for dental and orthopaedic care

Growth Strategies and Future Outlook

Product Diversification:

  • Expansion into digital dentistry solutions
  • Disinfectants and hygiene products portfolio
  • 3D printing resin portfolio expansion
  • New product range "Oradox" rollout

Market Development:

  • Aggressive penetration into Tier II & III Indian markets
  • Strengthening dealer and distributor network
  • Ecommerce expansion through Prevest Direct platform
  • Global market entry into new countries

Operational Initiatives:

  • Import substitution of raw materials resulting in cost savings
  • Indigenous raw material localization
  • R&D focus on product innovation and development
  • Digital dentistry workflow expansion

Financial Targets:

  • Consistent and sustainable growth trajectory
  • Strong financial position maintenance
  • Operational efficiency improvements

Awards and Recognition

  • ASSOCHAM 12th Global SME Excellence Awards
  • TRADE CONCLAVE Vyapar Ratna Award
  • 3D GEM Awards 2025